PJT Partners

PJT · NYSE

$136.94+$0.72 (+0.53%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $136.22

PJT analyst rating

BuyConsensus of 5 analysts over the last 12 months. 60% rate it a buy.

Strong buy0
Buy3
Hold2
Underperform0
Sell0

12-month price target · 6 analysts

Average $187.27 (+36.8% upside)

Low: $172.71
Now: $136.94
High: $204.75

Upgrades and downgrades

The latest rating actions, newest first

PJT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Oct 7, 2026	Maintains	Neutral	$176.00 → $165.00	43%
Keefe, Bruyette & Woods	Oct 7, 2026	Downgrade	Outperform → Market Perform	$195.00 → $159.00	21%
Goldman Sachs	Oct 1, 2026	Maintains	Buy	$203.00 → $182.00	50%
BMO Capital	Aug 3, 2026	Maintains	Outperform	$183.00 → $194.00	56%
Keefe, Bruyette & Woods	Jul 29, 2026	Maintains	Outperform	$185.00 → $195.00	21%
Keefe, Bruyette & Woods	Jul 10, 2026	Maintains	Outperform	$175.00 → $185.00	21%
UBS	Jul 8, 2026	Maintains	Neutral	$160.00 → $162.00	43%
UBS	Apr 29, 2026	Maintains	Neutral	$152.00 → $160.00	43%
Keefe, Bruyette & Woods	Apr 29, 2026	Maintains	Outperform	$166.00 → $175.00	50%
UBS	Apr 8, 2026	Maintains	Neutral	$151.00 → $152.00	43%

The case for and against

Updated Jan 16, 2025

Bull case

PJT Partners Inc. is poised for a positive outlook, driven by significantly higher revenues in its Park Hill business, particularly from Private Equity and Private Capital Solutions, indicating strong demand and growth potential. The firm has reported a record high mandate count and an elevated restructuring activity, suggesting robust engagement and ongoing needs in the market environment for liability management. Furthermore, management's expectations for improved fundraising trends and M&A activity bolster the confidence for sustained growth, highlighting PJT's strategic positioning to capitalize on evolving market conditions.

Bear case

PJT Partners Inc. has demonstrated a solid adjusted compratio of 69.5%, which aligns with internal estimates but falls slightly short of consensus expectations, highlighting a potential weakness in operational efficiency. The firm is heavily reliant on restructuring revenue, and despite a prominent growth trajectory among M&A boutiques, there are concerning signs of a lackluster visible pipeline, coupled with a valuation nearing fair value with limited price upside. The anticipated risk of a recession poses a significant threat to M&A volumes and overall capital market activity, which could overshadow any potential benefits from increased restructuring activity.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.